tirzepatide protein intake optimization research Nutritional priorities to support GLP‐1 therapy for obesity: A joint Advisory from the American Optimizing Nutrition and Protein on

Key takeaways Semaglutide is the active ingredient in Ozempic, an FDA-approved injection to lower blood sugar in the treatment of Type 2 diabetes and reduce cardiovascular and kidney risk in certain populations

Creatine Monohydrate Bovine Hydrolyzed Collagen Hyaluronic Acid Beyond these recommendations, we always suggest running micronutrient tests on your patients taking GLP-1 agonists

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

Lexicomp [online database]

Eur J Clin Investig 30(4):317324

It should be noted that this gastric emptying effect tends to attenuate with chronic therapy, as documented in the MHRA Summary of Product Characteristics (SmPC)